Transcatheter devices used in the management of patients with congenital heart disease

References

• King TD, Thompson SL, Steiner C, Mills NL. Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA235, 2506–2509 (1976).
   PubMed Web of Science ®Google Scholar
• Hausdorf G, Kaulitz R, Paul T, Carminati M, Lock J. Transcatheter closure of atrial septal defect with a new flexible, self-centering device (the STARFlex Occluder). Am. J. Cardiol.84(9), 1113–1116, A10 (1999).
   PubMed Web of Science ®Google Scholar
• Zahn EM, Wilson N, Cutright W, Latson LA. Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system. Circulation104(6), 711–716 (2001).
   PubMedGoogle Scholar
• Sideris EB, Sideris SE, Thanopoulos BD, Ehly RL, Fowlkes JP. Transvenous atrial septal defect occlusion by the buttoned device. Am. J. Cardiol.66(20), 1524–1526 (1990).
   PubMed Web of Science ®Google Scholar
• Rao PS, Berger F, Rey C et al. Results of transvenous occlusion of secundum atrial septal defects with the fourth generation buttoned device: comparison with first, second and third generation devices. International Buttoned Device Trial Group. J. Am. Coll. Cardiol.36(2), 583–592 (2000).
   PubMed Web of Science ®Google Scholar
• O’Laughlin MP. Microvena atrial septal defect occlusion device – update 2000. J. Interven. Cardiol.14(1), 77–80 (2001).
   PubMedGoogle Scholar
• Hausdorf G, Schneider M, Franzbach B, Kampmann C, Kargus K, Goeldner B. Transcatheter closure of secundum atrial septal defects with the atrial septal defect occlusion system (ASDOS): initial experience in children. Heart75(1), 83–88 (1996).
   PubMedGoogle Scholar
• Anderson RH, Lenox CC, Zuberbuhler JR. The morphology of ventricular septal defects. Perspect. Pediatr. Pathol.8, 235–268 (1984).
   PubMedGoogle Scholar
• Sharafuddin MJ, Gu X, Titus JL, Urness M, Cervera-Ceballos JJ, Amplatz K. Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model. Circulation95(8), 2162–2168 (1997). Erratum in Circulation97(4), 413 (1998).
   PubMed Web of Science ®Google Scholar
• Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience [see comment]. Catheter. Cardiovasc. Diagn.42(4), 388–393 (1997).
   PubMedGoogle Scholar
• Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K, Amplatzer I. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J. Am. Coll. Cardiol.39, 1836–1844 (2002).
   PubMed Web of Science ®Google Scholar
• Butera G, De Rosa G, Chessa M et al. Transcatheter closure of atrial septal defect in young children: results and follow-up. J. Am. Coll. Cardiol.42, 241–245 (2003).
   PubMed Web of Science ®Google Scholar
• Hill SL, Berul CI, Patel HT et al. Early ECG abnormalities associated with transcatheter closure of atrial septal defects using the Amplatzer septal occluder. J. Interv. Card. Electrophysiol.4, 469–474 (2000).
   PubMed Web of Science ®Google Scholar
• Hessling G, Hyca S, Brockmeier K, Ulmer HE. Cardiac dysrhythmias in pediatric patients before and 1 year after transcatheter closure of atrial septal defects using the amplatzer septal occluder. Pediatr. Cardiol.24, 259–262 (2003).
   PubMed Web of Science ®Google Scholar
• Ries MW, Kampmann C, Rupprecht HJ, Hintereder G, Hafner G, Meyer J. Nickel release after implantation of the Amplatzer occluder. Am. Heart J.145(4), 737–741 (2003).
   PubMed Web of Science ®Google Scholar
• Lai DW, Saver JL, Araujo JA, Reidl M, Tobis J. Pericarditis associated with nickel hypersensitivity to the Amplatzer occluder device: a case report. Catheter. Cardiovasc. Interven.66(3), 424–426 (2005).
   PubMed Web of Science ®Google Scholar
• Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter. Cardiovasc. Interv.63, 496–502 (2004).
   PubMed Web of Science ®Google Scholar
• Ewert P, Kretschmar O, Peters B et al. Preliminary experience with a new 18 mm Amplatzer PFO occluder for small persistent foramen ovale. Catheter. Cardiovasc. Interven.59(4), 518–521 (2003).
   PubMed Web of Science ®Google Scholar
• Waight DJ, Cao QL, Hijazi ZM. Closure of patent foramen ovale in patients with orthodeoxia-platypnea using the amplatzer devices [see comment]. Catheter. Cardiovasc. Interven.50(2), 195–198 (2000).
   PubMed Web of Science ®Google Scholar
• Hong TE, Thaler D, Brorson J, Heitschmidt M, Hijazi ZM. Transcatheter closure of patent foramen ovale associated with paradoxical embolism using the amplatzer PFO occluder: initial and intermediate-term results of the US multicenter clinical trial. Catheter. Cardiovasc. Interven.60(4), 524–528 (2003).
   PubMed Web of Science ®Google Scholar
• Trepels T, Zeplin H, Sievert H et al. Cardiac perforation following transcatheter PFO closure. Catheter. Cardiovasc. Interven.58(1), 111–113 (2003).
   PubMed Web of Science ®Google Scholar
• Krumsdorf U, Ostermayer S, Billinger K et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients [see comment]. J. Am. Coll. Cardiol.43(2), 302–309 (2004).
   PubMed Web of Science ®Google Scholar
• Braun M, Gliech V, Boscheri A et al. Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism. Periprocedural safety and mid-term follow-up results of three different device occluder systems [see comment]. Eur. Heart J.25(5), 424–430 (2004).
   PubMed Web of Science ®Google Scholar
• Amin Z, Gu X, Berry JM et al. New device for closure of muscular ventricular septal defects in a canine model. Circulation100, 320–328 (1999).
   PubMed Web of Science ®Google Scholar
• Thanopoulos BD, Tsaousis GS, Konstadopoulou GN, Zarayelyan AG. Transcatheter closure of muscular ventricular septal defects with the amplatzer ventricular septal defect occluder: initial clinical applications in children. J. Am. Coll. Cardiol.33(5), 1395–1399 (1999).
   PubMed Web of Science ®Google Scholar
• Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J. Am. Coll. Cardiol.43(7), 1257–1263 (2004).
   PubMed Web of Science ®Google Scholar
• Thanopoulos BD, Rigby ML. Outcome of transcatheter closure of muscular ventricular septal defects with the Amplatzer ventricular septal defect occluder. Heart91(4), 513–516 (2005).
   PubMed Web of Science ®Google Scholar
• Bacha EA, Cao QL, Galantowicz ME et al. Multicenter experience with perventricular device closure of muscular ventricular septal defects. Pediatr. Cardiol.26(2), 169–175 (2005).
   PubMed Web of Science ®Google Scholar
• Bacha EA, Cao QL, Starr JP, Waight D, Ebeid MR, Hijazi ZM. Perventricular device closure of muscular ventricular septal defects on the beating heart: technique and results. J. Thorac. Cardiovasc. Surg.126(6), 1718–1723 (2003).
   PubMed Web of Science ®Google Scholar
• Goldstein JA, Casserly IP, Balzer DT, Lee R, Lasala JM. Transcatheter closure of recurrent postmyocardial infarction ventricular septal defects utilizing the Amplatzer postinfarction VSD device: a case series. Catheter. Cardiovasc. Interven.59(2), 238–243 (2003).
   PubMed Web of Science ®Google Scholar
• Holzer R, Balzer D, Amin Z et al. Transcatheter closure of postinfarction ventricular septal defects using the new Amplatzer muscular VSD occluder: results of a U.S. Registry. Catheter. Cardiovasc. Interven.61(2), 196–201 (2004).
   PubMed Web of Science ®Google Scholar
• Crenshaw BS, Granger CB, Birnbaum Y et al. Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators. Circulation101, 27–32 (2000).
   PubMed Web of Science ®Google Scholar
• Cooley DA. Postinfarction ventricular septal rupture. Semin. Thorac. Cardiovasc. Surg.10, 100–104 (1998).
   PubMedGoogle Scholar
• Dalrymple-Hay MJ, Monro JL, Livesey SA, Lamb RK. Postinfarction ventricular septal rupture: the Wessex experience. Semin. Thorac. Cardiovasc. Surg.10, 111–116 (1998).
   PubMedGoogle Scholar
• Rigby ML, Redington AN. Primary transcatheter umbrella closure of perimembranous ventricular septal defect. Br. Heart J.72, 368–371 (1994).
   PubMedGoogle Scholar
• Gu X, Han YM, Titus JL et al. Transcatheter closure of membranous ventricular septal defects with a new nitinol prosthesis in a natural swine model. Catheter. Cardiovasc. Interven.50(4), 502–509 (2000).
   PubMed Web of Science ®Google Scholar
• Hijazi ZM, Hakim F, Haweleh AA et al. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience. Catheter. Cardiovasc. Interven.56(4), 508–515 (2002).
   PubMed Web of Science ®Google Scholar
• Holzer R, De Giovanni JV, Walsh KP et al. Transcatheter closure of perimembranous ventricular septal defects using the Amplatzer Membranous VSD Occluder: immediate and mid term results of an international registry. Catheter. Cardiovasc. Interv. (2006).
   PubMedGoogle Scholar
• Fu YC, Bass J, Amin Z et al. Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer Membranous VSD Occluder: results of the U.S. Phase I trial. J. Am. Coll. Cardiol.47, 319–325 (2006).
   PubMed Web of Science ®Google Scholar
• Masura J, Gao W, Gavora P et al. Percutaneous closure of perimembranous ventricular septal defects with the eccentric Amplatzer device: multicenter follow-up study. Pediatr. Cardiol.26(3), 216–219 (2005).
   PubMed Web of Science ®Google Scholar
• Yip WC, Zimmerman F, Hijazi ZM. Heart block and empirical therapy after transcatheter closure of perimembranous ventricular septal defect. Catheter. Cardiovasc. Interven.66(3), 436–441 (2005).
   PubMed Web of Science ®Google Scholar
• Amin Z, Danford DA, Lof J, Duncan KF, Froemming S. Intraoperative device closure of perimembranous ventricular septal defects without cardiopulmonary bypass: preliminary results with the perventricular technique. J. Thorac. Cardiovasc. Surg.127(1), 234–241 (2004).
   PubMed Web of Science ®Google Scholar
• Lock JE, Rome JJ, Davis R et al. Transcatheter closure of atrial septal defects. Experimental studies. Circulation79(5), 1091–1099 (1989).
   PubMed Web of Science ®Google Scholar
• Latson LA, Benson LN, Hellenbrand WF, Mullins CE, Lock JF. Transcatheter closure of ASD–early results of multi-center trial of the Bard clamshell septal occluder. Circulation84(Suppl. II), 544 (1991).
   Google Scholar
• Bridges ND, Perry SB, Parness I, Keane JF, Lock JE. Transcatheter closure of a large patent ductus arteriosus with the clamshell septal umbrella. J. Am. Coll. Cardiol.18(5), 1297–1302 (1991).
   PubMed Web of Science ®Google Scholar
• Schlesinger AE, Folz SJ, Beekman RH. Transcatheter atrial septal defect occlusion devices: normal radiographic appearances and complications. J. Vasc. Interv. Radiol.3(3), 527–533 (1992).
   PubMedGoogle Scholar
• Latson LA. The CardioSEAL device: history, techniques, results. J. Interv. Cardiol.11, 501–505 (1998).
   Web of Science ®Google Scholar
• Mullins CE. Cardiac Catheterization in Congenital Heart Disease. Malden (Ed). Blackwell, MA, USA (2006).
   Google Scholar
• Carminati M, Giusti S, Hausdorf G et al. A European multicentric experience using the CardioSEal and Starflex double umbrella devices to close interatrial communications holes within the oval fossa. Cardiol. Young10(5), 519–526 (2000).
   PubMed Web of Science ®Google Scholar
• Vincent RN, Raviele AA, Diehl HJ. Single-center experience with the HELEX septal occluder for closure of atrial septal defects in children. J. Interven. Cardiol.16(1), 79–82 (2003).
   PubMedGoogle Scholar
• Sievert H, Horvath K, Zadan E et al. Patent foramen ovale closure in patients with transient ischemia attack/stroke. J. Interven. Cardiol.14(2), 261–266 (2001).
   PubMedGoogle Scholar
• Cheatham JP, Hill SL, Chisolm JL. Initial results using the new Cribriforme Amplatzer Septal Occluder for transcatheter closure of multifenestrated atrial septal defects with septal aneurysm. Catheter. Cardiovasc. Interv.60, 126 (2003) (Abstract).
   Google Scholar
• Porstmann W, Wierny L, Warnke H. [Closure of ductus arteriosus persistens without thoracotomy. 2]. Fortschr. Geb. Rontgenstr. Nuklearmed.109, 133–148 (1968).
   PubMedGoogle Scholar
• Wallace S, Gianturco C, Anderson JH, Goldstein HM, Davis LJ, Bree RL. Therapeutic vascular occlusion utilizing steel coil technique: clinical applications. Am. J. Roentgenol.127(3), 381–387 (1976).
   PubMed Web of Science ®Google Scholar
• Perry SB, Radtke W, Fellows KE, Keane JF, Lock JE. Coil embolization to occlude aortopulmonary collateral vessels and shunts in patients with congenital heart disease. J. Am. Coll. Cardiol.13(1), 100–108 (1989).
   PubMed Web of Science ®Google Scholar
• Cambier PA, Kirby WC, Wortham DC, Moore JW. Percutaneous closure of the small (less than 2.5 mm) patent ductus arteriosus using coil embolization. Am. J. Cardiol.69(8), 815–816 (1992).
   PubMed Web of Science ®Google Scholar
• Uzun O, Hancock S, Parsons JM, Dickinson DF, Gibbs JL. Transcatheter occlusion of the arterial duct with Cook detachable coils: early experience. Heart76(3), 269–273 (1996).
   PubMed Web of Science ®Google Scholar
• Masura J, Walsh KP, Thanopoulous B et al. Catheter closure of moderate- to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results. J. Am. Coll. Cardiol.31(4), 878–882 (1998).
   PubMed Web of Science ®Google Scholar
• Celiker A, Aypar E, Karagoz T, Dilber E, Ceviz N. Transcatheter closure of patent ductus arteriosus with Nit-Occlud coils. Catheter. Cardiovasc. Interven.65(4), 569–576 (2005).
   PubMed Web of Science ®Google Scholar
• Chisolm JL, Hill SL, Hardin J et al. Initial experience with the Nit-Occlud PDA Occlusion System for closure of patent ductus arteriosus. Catheter. Cardiovasc. Interv.60, 126 (2003) (Abstract).
   Google Scholar
• Holzer R, Cao QL, Sandhu S, Hijazi ZM. The Amplatzer vascular plug–an addition to our interventional armantarium. Pediatr. Cardiol. Today2, 6–8 (2004).
   Google Scholar
• Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J. Am. Coll. Cardiol.44(3), 513–519 (2004).
   PubMed Web of Science ®Google Scholar
• Hill SL, Hijazi ZM, Hellenbrand WE, Cheatham JP. Evaluation of the AMPLATZER vascular plug for embolization of peripheral vascular malformations associated with congenital heart disease. Catheter. Cardiovasc. Interven.67(1), 113–119 (2006).
   PubMed Web of Science ®Google Scholar
• Hoyer MH. Novel use of the Amplatzer plug for closure of a patent ductus arteriosus [see comment]. Catheter. Cardiovasc. Interven.65(4), 577–580 (2005).
   PubMed Web of Science ®Google Scholar
• Cheatham JP. Not so fast with that novel use: does AVP = PDA? [comment]. Catheter. Cardiovasc. Interven.65(4), 581–583 (2005).
   PubMed Web of Science ®Google Scholar
• Patel HT, Cao QL, Rhodes J, Hijazi ZM. Long-term outcome of transcatheter coil closure of small to large patent ductus arteriosus. Catheter. Cardiovasc. Interven.47(4), 457–461 (1999).
   PubMed Web of Science ®Google Scholar
• Hijazi ZM, Geggel RL. Transcatheter closure of large patent ductus arteriosus (> or = 4 mm) with multiple Gianturco coils: immediate and mid-term results. Heart76(6), 536–540 (1996).
   PubMed Web of Science ®Google Scholar
• Grifka RG, Mullins CE, Gianturco C et al. New Gianturco-Grifka vascular occlusion device. Initial studies in a canine model. Circulation91, 1840–1846 (1995).
   PubMed Web of Science ®Google Scholar
• Hoyer MH, Leon RA, Fricker FJ. Transcatheter closure of modified Blalock-Taussig shunt with Gianturco-Grifka Vascular Occlusion Device [see comment]. Catheter. Cardiovasc. Interven.48(4), 365–367 (1999).
   PubMed Web of Science ®Google Scholar
• Ebeid MR, Gaymes CH, Smith JC, Braden DS, Joransen JA. Gianturco-Grifka vascular occlusion device for closure of patent ductus arteriosus. Am. J. Cardiol.87, 657–660 (2001).
   PubMed Web of Science ®Google Scholar
• Mullins CE, O’Laughlin MP, Vick GW III et al. Implantation of balloon-expandable intravascular grafts by catheterization in pulmonary arteries and systemic veins. Circulation77, 188–199 (1988).
   PubMed Web of Science ®Google Scholar
• O’Laughlin MP, Perry SB, Lock JE, Mullins CE. Use of endovascular stents in congenital heart disease. Circulation83, 1923–1939 (1991).
   PubMed Web of Science ®Google Scholar
• Cheatham JP. Stenting of coarctation of the aorta. Catheter. Cardiovasc. Interv.54, 112–125 (2001).
   PubMed Web of Science ®Google Scholar